9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment.

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aiming at finding new solutions for fighting glioblastoma multiforme, one of the most aggressive and lethal human cancer, here an in vitro validation of multifunctional nanovectors for drug delivery and hyperthermia therapy is proposed. Hybrid magnetic lipid nanoparticles have been fully characterized and tested on a multi-cellular complex model resembling the tumor microenvironment. Investigations of cancer therapy based on a physical approach (namely hyperthermia) and on a pharmaceutical approach (by exploiting the chemotherapeutic drug temozolomide) have been extensively carried out, by evaluating its antiproliferative and pro-apoptotic effects on 3D models of glioblastoma multiforme. A systematic study of transcytosis and endocytosis mechanisms has been moreover performed with multiple complimentary investigations, besides a detailed description of local temperature increments following hyperthermia application. Finally, an in-depth proteomic analysis corroborated the obtained findings, which can be summarized in the preparation of a versatile, multifunctional, and effective nanoplatform able to overcome the blood-brain barrier and to induce powerful anti-cancer effects on in vitro complex models.

          Related collections

          Author and article information

          Journal
          Nanoscale
          Nanoscale
          Royal Society of Chemistry (RSC)
          2040-3372
          2040-3364
          Nov 28 2019
          : 11
          : 44
          Affiliations
          [1 ] Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy. attilio.marino@iit.it gianni.ciofani@iit.it.
          [2 ] Politecnico di Torino, Department of Mechanical and Aerospace Engineering, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.
          [3 ] IRCCS Istituto Giannina Gaslini, Via Gerolamo Gaslini 5, 16147 Genova, Italy.
          [4 ] Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy. attilio.marino@iit.it gianni.ciofani@iit.it and Scuola Superiore Sant'Anna, The Biorobotics Institute, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy.
          [5 ] Istituto Italiano di Tecnologia, Center for Advanced Biomaterials for Health Care, Largo Barsanti e Matteucci 53, 80125 Naples, Italy.
          [6 ] Kanazawa University, Nano Life Science Institute (WPI-NanoLSI), Kakuma-Machi, 920-1192 Kanazawa, Japan and Waseda University, Research Institute for Science and Engineering, 3-4-1 Ohkubo, Shinjuku-ku, 169-8555 Tokyo, Japan.
          [7 ] Osaka University, Institute for Protein Research, 3-2 Yamadaoka, Suita-Shi, 565-0871 Osaka, Japan and PRESTO, Japan Science and Technology Agency (JST), 4-1-8 Honcho, Kawaguchi, 332-0012 Saitama, Japan.
          [8 ] Osaka University, Institute for Protein Research, 3-2 Yamadaoka, Suita-Shi, 565-0871 Osaka, Japan.
          [9 ] Istituto Italiano di Tecnologia, Smart Bio-Interfaces, Viale Rinaldo Piaggio 34, 56025 Pontedera, Italy. attilio.marino@iit.it gianni.ciofani@iit.it and Politecnico di Torino, Department of Mechanical and Aerospace Engineering, Corso Duca degli Abruzzi 24, 10129 Torino, Italy.
          Article
          EMS84941
          10.1039/c9nr07976a
          6867905
          31663592
          7b56057a-9c37-4dd8-8e4f-0cee74fdae2a
          History

          Comments

          Comment on this article